And the formulation that carried GHK-Cu into controlled human testing under a pharmaceutical generic name was a topical gel , not an injection the one time the compound was developed with regulatory intent, the route chosen was the skin
doi: 10.21037/hbsn-20-671 46
PrymaLab supplies PT-141 (bremelanotide) as a preloaded 3ml autoinjector pen at 10mg/ml, research-use-only, with transparent sourcing and batch traceability
CJC-1295 with DAC laboratory research
evaluating metformin, liraglutide, and combination therapy (metformin 1000 mg BID + liraglutide 1.2 mg/day), only the latter treatment resulted in significant decrease in body weight and androstenedione levels [61]
Injections deliver superior absorption compared to oral supplements and offer faster, more noticeable results